FAAS
IMGN

First Allied Advisory Services’s Immunogen Inc IMGN Stock Holding History

First Allied Advisory Services’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-13,113
Closed -$196K – 1162
2015
Q2 		$196K Buy
13,113
+1,889
+17% +$20.7K 0.01% 1036
2015
Q1 		$106K Buy
+11,224
New +$81.3K 0.01% 1025

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

First Allied Advisory Services's IMGN Position: Q3 2015 in Review

First Allied Advisory Services sold out of Immunogen Inc (IMGN) in Q3 2015, closing a stake of 13,113 shares — an estimated $196K sold.

First Allied Advisory Services first reported a position in IMGN in Q1 2015 and held it in 2 quarters. The position peaked at $196K in Q2 2015. 151 funds tracked by Wall St. Rank hold IMGN as of Q3 2015.

  • First Allied Advisory Services reported no remaining Immunogen Inc position as of Q3 2015 after selling out during the quarter.
  • First Allied Advisory Services sold 13,113 Immunogen Inc shares in Q3 2015, an estimated $196K.
  • First Allied Advisory Services first reported a position in Immunogen Inc in Q1 2015 and held it in 2 quarters.
  • First Allied Advisory Services's Immunogen Inc position peaked at $196K in Q2 2015.
  • 151 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2015.

Based on First Allied Advisory Services's 13F filing for Q3 2015, filed 12 Nov 2015.